Seer Investor Relations Material
Latest events
Q2 2025
Seer
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seer Inc
Access all reports
Seer Inc develops life sciences technologies intended to enable discovery of proteomic biomarkers with high throughput and precision. The company’s products support research in areas such as biomarker identification, disease detection, and therapeutic development. Seer serves pharmaceutical, academic, and research institutions in the life sciences sector. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Key slides for Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
SEER
Country
🇺🇸 United States